Related Experiment Video
Updated: Jan 17, 2026

08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
6.6K
How embryo retention affects assisted reproductive technology outcomes: a systematic review and meta-analysis
Arezoo Maleki-Hajiagha1,2, Rana Karimi3, Neda Emami3
1Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Pour Sina St., Ghods St., Keshavarz Blvd., Tehran, Iran.
Archives of Gynecology and Obstetrics
|September 16, 2025
Summary
Retransferring retained embryos after embryo transfer (ET) significantly reduces clinical pregnancy and live birth rates. This practice also substantially increases the risk of ectopic pregnancy (EP), impacting assisted reproductive technology (ART) success.
Area of Science:
- Reproductive Medicine
- Assisted Reproductive Technology (ART)
- Embryo Transfer (ET)
Background:
- Embryo retention (ER) during embryo transfer (ET) raises concerns regarding assisted reproductive technology (ART) outcomes.
- Technical difficulties in ET can compromise implantation and increase complications.
Purpose of the Study:
- To systematically review and meta-analyze the impact of retransferring retained embryos on ART outcomes.
- Key outcomes evaluated include clinical pregnancy rate (CPR), biochemical pregnancy rate (BPR), ectopic pregnancy rate (EP), miscarriage rate (MR), and live birth rate (LBR).
Main Methods:
- Systematic literature search of PubMed, Scopus, and Cochrane databases.
- Pooled Mantel-Haenszel odds ratios (OR) with 95% confidence intervals (CI) were calculated.
- Subgroup and sensitivity analyses were performed based on study design, ET technique, and risk of bias.
Main Results:
- Retransferring retained embryos significantly reduced CPR (OR ≈ 0.75) and LBR.
- A substantial increase in EP risk was observed (OR ≈ 2.36).
- Matched study designs and afterload ET techniques showed more pronounced negative effects.
Conclusions:
- Embryo retention negatively impacts ART success, decreasing pregnancy and live birth rates.
- ER elevates the risk of ectopic pregnancy, necessitating protocol refinement.
- Further research into ER mechanisms and prospective studies are needed to optimize management.
Related Concept Videos
In Vitro Fertilization
894
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
894
Meiosis II
207.1K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
207.1K
Infertility in Females
3.7K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
3.7K

